A subscriber-only roundtable discussion hosted by MIT Technology Review explores the frontier of longevity research, focusing on cellular reprogramming as a potential treatment to reverse aging.
<p><strong>Listen to the session or watch below</strong></p>
<figure class="wp-block-audio"><audio controls src="https://wp.technologyreview.com/wp-content/uploads/2026/06/GMT20260630-153003_Recording.m4a"></audio></figure>
<p>Billions of dollars are flooding into efforts to reverse aging as scientists explore ways to return cells to a younger state. But how far off are these experimental treatments? Will they really work? Watch a conversation exploring longevity’s new focus.<br></p>
<p><strong><strong><strong><strong>Speakers</strong></strong></strong><em><strong><strong><strong>: </strong></strong></strong></em></strong>Mary Beth Griggs, science editor and <a href="https://www.technologyreview.com/author/jessica-hamzelou/" data-type="link" data-id="https://www.technologyreview.com/author/jessica-hamzelou/">Jessica Hamzelou</a>, senior biotechnology reporter</p>
<figure class="wp-block-embed is-type-video is-provider-vimeo wp-block-embed-vimeo wp-embed-aspect-16-9 wp-has-aspect-ratio"><div class="wp-block-embed__wrapper">
<iframe title="Roundtables: Longevity's Next Frontier: "Reprogramming" Your Body" src="https://player.vimeo.com/video/1205877334?dnt=1&app_id=122963" width="500" height="281" frameborder="0" allow="autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share" referrerpolicy="strict-origin-when-cross-origin"></iframe>
</div></figure>
<p><strong><em><strong><strong><em><strong><em><strong>Recorded on</strong></em></strong> June 30, 2026</em></strong></strong></em></strong></p>
<p><strong>Related Stories:</strong></p>
<ul class="wp-block-list">
<li><a href="https://www.technologyreview.com/2026/06/12/1138829/reprogramming-buzziest-approach-reversing-aging-right-now" data-type="link" data-id="https://www.technologyreview.com/2026/06/12/1138829/reprogramming-buzziest-approach-reversing-aging-right-now">Why “reprogramming” is the buzziest approach to reversing aging right now</a></li>
<li><a href="https://www.technologyreview.com/2022/10/25/1061644/how-to-be-young-again/" data-type="link" data-id="https://www.technologyreview.com/2022/10/25/1061644/how-to-be-young-again/">How scientists want to make you young again</a></li>
<li><a href="https://www.technologyreview.com/2023/03/08/1069523/sam-altman-investment-180-million-retro-biosciences-longevity-death/" data-type="link" data-id="https://www.technologyreview.com/2023/03/08/1069523/sam-altman-investment-180-million-retro-biosciences-longevity-death/">Sam Altman invested $180 million into a company trying to delay death</a></li>
</ul>
# Roundtables: Longevity’s Next Frontier: “Reprogramming” Your Body
Source: [https://www.technologyreview.com/2026/06/30/1139958/roundtables-longevitys-next-frontier-reprogramming-your-body](https://www.technologyreview.com/2026/06/30/1139958/roundtables-longevitys-next-frontier-reprogramming-your-body)
[Skip to Content](https://www.technologyreview.com/2026/06/30/1139958/roundtables-longevitys-next-frontier-reprogramming-your-body#content)
Watch a subscriber\-only discussion exploring longevity's new focus\.
Available only for MIT Alumni and subscribers\.
**Listen to the session or watch below**
Billions of dollars are flooding into efforts to reverse aging as scientists explore ways to return cells to a younger state\. But how far off are these experimental treatments? Will they really work? Watch a conversation exploring longevity's new focus\.
********Speakers*************:*********Mary Beth Griggs, science editor and[Jessica Hamzelou](https://www.technologyreview.com/author/jessica-hamzelou/), senior biotechnology reporter
### Deep Dive
### Biotechnology and health
### Stay connected
Illustration by Rose Wong
## Get the latest updates from MIT Technology Review
Discover special offers, top stories, upcoming events, and more\.
A biotech company has dosed its first volunteer in a clinical trial for an experimental glaucoma treatment that uses cellular reprogramming to reverse age-related damage, part of a broader trend toward rejuvenation therapies.
This newsletter covers two major tech stories: a biotech company's first human trial of 'reprogramming' cells to reverse aging, and the growing field of interoception research. It also notes SpaceX's record-breaking IPO.
Brian Armstrong announces that NewLimit has developed a prototype drug that reverses cellular aging in human cells, with a clinical trial scheduled for next year, and has raised $435M in Series C funding led by Founders Fund.
DeepMind's Co-Scientist is helping biologists identify genetic factors that reverse cellular aging by mining literature and analyzing screening data, reducing analysis time from months to days.
David Sinclair plans to test an oral epigenetic reprogramming drug, SL-100, in the XPrize competition for whole-body rejuvenation, aiming for a 10-year age reversal.